s6y
Company name or ticker
Search
Ernexa Therapeutics Inc.
424B3
Prospectus filed pursuant to Rule 424(b)(3)
Filed
Thursday, May 12, 2022
Accession number
0001140361-22-018769
Documents
424B3
424B3
On sec.gov
Filing index
All files
Complete submission text
SGML header